Miquel Vila-Perelló, SpliceBio CEO
October 17, 2023 03:00 AM EDT
Deals
Pharma
Cell/Gene Tx

Spark lines up next reti­nal gene ther­a­py pact in Barcelona

Kyle LaHucik

Senior Reporter

When it nabbed the first FDA ap­proval for a reti­nal gene ther­a­py in 2017, Spark Ther­a­peu­tics helped launch a field of biotechs look­ing to treat …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

A service from the Financial Times